# General Summary of Protein Data


## Introduction to the General Summary

This summary provides an overview of the protein analyses results obtained through the use of various bioinformatics tools. 
The proteins where selected from the set of 506 proteins obtained from literature review as potential antigens for uterine carcinosarcoma.
Each protein analyzed is represented in the table below, with detailed information provided for each entry (a few entries have failed
when computing the pipeline and they will be manually reviewed, but is a very small minority). 


This document aims to provide a quick and comprehensive summary of the key metrics and findings for each protein, serving as an entry point
to more in-depth analyses.

### Tools Utilized
- **UniProt XML file**: Used to gather protein-specific information, including isoforms, biological attributes and identifiers in other databases.
- **Discotope 3.0**: Utilized for predicting potential epitope regions based on structural data.
- **Tango**: Conducted to assess the likelihood of residue-level aggregation.
- **Expression Data**: A comparison of protein expression levels across normal and disease states whas obtained from GTEX and TCGA using biomart API.
- **Isoform Analysis**: Alignment of protein isoforms to identify structural and functional differences was performed with BioPython.
- **STRING-DB API**: Used to retrieve interactors and homologous proteins for each target.
- **Ensembl REST API**: Employed to decode Ensembl IDs and retrieve homologous human proteins.
- **AlphaFold**: Used to obtain full structural data for the proteins (modelled).
- **PDB**: Used to obtain structural data for the proteins, particularly biological assemblies.

### How to Interpret the Results
- **Uniprot ID**: A clickable link to access detailed information for each protein.
- **AUC**: Indicates the accuracy of distinguishing normal from disease states based on expression data. A higher value suggests better discriminatory power. *This information is based on transcriptomics data from GTEX and TCGA and could not behave in the same way for proteins.*
- **Fold Change**: A measure of the difference in expression levels between conditions. Values greater than 1.0 indicate upregulation. High AUCs with small fold changes may indicate consistent differences but subtle ones and could be hard to see differences at protein level.
- **Up/Down regulation**: -1 for downregulated, 1 for upregulated, 2 for both, in the first column expressing this, coming from the literature. On the transcriptomics column: values, if available, from GTEX and TCGA, that could or could not could not behave in the same way for proteins.
- **Glycosylation Sites & Modified Residues**: Numbers of residues that could undergo to specific modifications that block their access by the antibodies when developing the assays.
- **Discotope Epitope Count**: The number of residues predicted to be part of epitopes, important for immunogenicity studies, but what is important is to observe them in the structure.
- **Interactor Count & Homolog Count**: Quantitative data on interactors and homologous proteins. Homologs are just computed from human proteins, this analysis could be extended to other organsims if necessary. High number of interactors and homologs are not preffered.
- **Isoforms**: The total number of protein isoforms analyzed, which may indicate structural or functional diversity.
- **Aggregation Sites**: Number of residues with high aggregation propensity, which could affect protein stability and function.
- **Biological Assemblies**: The maximum number of UniProt IDs in a biological assembly (heterodimers) and count of the same Uniprot ID in a biological assembly (homodimers). This provide insights into protein complexes beyond binary interactions marked in STRING database. The higher the number of uniprot IDs in a biological assembly or the homodimer count, the more complex the protein to design an antibody for.

Please refer to the individual detailed summaries for each protein for a deeper examination of residue-level information and specific analyses.
| Uniprot ID                              | Gene Name   | Protein Name   |   (transcriptomics) AUC |   (transcriptomics) Fold Change  | (transcriptomics) Up/Down Regulated    |   Seq Length |   Glycosylation Sites |   Modified Residues | Subcellular Location                                                                                |   Discotope Epitope Count |   Critical Aggregation Sites (>50) |   Interactor Count | Interactors                                                                                                                                                                                                                                                                                                                                                                                                                                                 |   Homolog Count | Homologs                                                                                                                                                                                                  | Max n_uniprots Homo   | Max n_uniprots Hetero   |   Number of Isoforms |
|:----------------------------------------|:------------|:---------------|------------------------:|---------------------------------:|:---------------------------------------|-------------:|----------------------:|--------------------:|:----------------------------------------------------------------------------------------------------|--------------------------:|-----------------------------------:|-------------------:|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------:|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:----------------------|:------------------------|---------------------:|
| [O60504](./O6/O60504/O60504_details.md) | SORBS3      | VINEX_HUMAN    |                    0.04 |                             1.16 | Downregulated                          |          671 |                     0 |                  10 | Cell junction \| Cytoplasm \| Cytoskeleton \| Cell junction \| Nucleus \| Cytoplasm \| Cytoskeleton |                        88 |                                  5 |                  4 | VCL \| TLN1 \| DLG5 \| PXN                                                                                                                                                                                                                                                                                                                                                                                                                                  |              12 | SH3GL3 \| SH3RF2 \| NCF4 \| SH3RF3 \| SH3GL1 \| SH3RF1 \| SORBS1 \| SH3GL2 \| SH3GLB2 \| SH3GLB1 \| SH3D19 \| SORBS2                                                                                      | 1                     | N/A                     |                    2 |
| [P17252](./P1/P17252/P17252_details.md) | PRKCA       | KPCA_HUMAN     |                    0.1  |                             1.22 | Downregulated                          |          672 |                     0 |                  14 | Cytoplasm \| Cell membrane \| Mitochondrion membrane \| Nucleus                                     |                       155 |                                 34 |                 50 | SDC4 \| PICK1 \| PRKCG \| RACK1 \| MTOR \| NCF1 \| PRKCD \| PRKCB \| PLD1 \| PLCG1 \| DLG4 \| MAPK3 \| ACTB \| EZR \| CACNA1C \| PLD2 \| PLCG2 \| CASP3 \| PLCB1 \| SLC9A3R1 \| FOS \| PPP1R1A \| PDPK1 \| BRAF \| ITPR1 \| HRAS \| PLCB3 \| TRPC3 \| ITPR3 \| PLCB4 \| EGFR \| KRAS \| SPHK1 \| MAPK1 \| PLCD1 \| EGLN2 \| NRAS \| EEF2K \| PPP2CA \| PLCB2 \| PLCE1 \| CACNA1F \| PLCD3 \| ITGB1 \| TRPV4 \| SPHK2 \| PPP2CB \| CACNA1S \| ITPR2 \| KCNN4 |               9 | PRKCB \| PKN2 \| PKN1 \| PRKCH \| PRKCZ \| PRKCI \| PRKCE \| PKN3 \| PRKCG                                                                                                                                | 1                     | N/A                     |                    0 |
| [P07585](./P0/P07585/P07585_details.md) | DCN         | PGS2_HUMAN     |                    0.05 |                             1.38 | Downregulated                          |          359 |                     4 |                   0 | Secreted \| Extracellular space \| Extracellular matrix \| Secreted                                 |                        77 |                                 17 |                 46 | EGFR \| TGFB1 \| FN1 \| ELN \| YBX3 \| TLR2 \| BGN \| YBX1 \| IGF1 \| TLR4 \| MET \| HSPG2 \| VCAN \| LUM \| P3H3 \| ACAN \| TGFB3 \| ERBB2 \| FGF7 \| MFAP2 \| VTN \| FGF10 \| FGF22 \| CCN2 \| FGF20 \| FMOD \| FGF16 \| FGF9 \| FGF18 \| COL14A1 \| FGF8 \| FGF6 \| FGF3 \| FGF4 \| SDC1 \| COL3A1 \| KDR \| COL1A2 \| COL1A1 \| ERBB4 \| EGF \| ERBB3 \| FBN1 \| FGF5 \| FGF17 \| SPARC                                                                 |              22 | LRRC4B \| LRRC19 \| FLRT1 \| LRRTM1 \| LRRTM4 \| LRRC4C \| FLRT3 \| PODNL1 \| LRRC4 \| LRRTM3 \| LRRC15 \| LRRC66 \| RTN4RL1 \| RTN4R \| FLRT2 \| LRTM1 \| PODN \| BGN \| GP1BA \| ASPN \| RTN4RL2 \| NYX | N/A                   | N/A                     |                    5 |
| [O94788](./O9/O94788/O94788_details.md) | ALDH1A2     | AL1A2_HUMAN    |                    0.09 |                             1.51 | Downregulated                          |          518 |                     0 |                   2 | Cytoplasm                                                                                           |                        88 |                                 13 |                 32 | CYP26A1 \| CYP26B1 \| CYP26C1 \| RDH10 \| RDH12 \| DHRS3 \| BCO1 \| RDH11 \| RDH5 \| RDH8 \| SDR16C5 \| AOX1 \| RDH16 \| DHRS4 \| DHRS9 \| CYP1A1 \| CYP3A7 \| CYP2S1 \| CYP3A4 \| CYP3A5 \| CYP4A22 \| CYP1A2 \| CYP4A11 \| ENSP00000480571 \| CYP2C8 \| CYP2B6 \| ALDH1A1 \| CYP2C9 \| CYP2C18 \| CYP2A6 \| HSD17B6 \| ALDH1A3                                                                                                                            |              17 | ALDH1L2 \| ALDH2 \| ALDH1L1 \| ALDH4A1 \| ALDH1A3 \| ALDH8A1 \| ALDH3A1 \| ALDH5A1 \| ALDH3B2 \| ALDH1B1 \| ALDH7A1 \| nan \| ALDH16A1 \| ALDH3B1 \| ALDH1A1 \| ALDH6A1 \| ALDH3A2                        | 4                     | N/A                     |                    4 |
| [O15247](./O1/O15247/O15247_details.md) | CLIC2       | CLIC2_HUMAN    |                    0.11 |                             1.25 | Downregulated                          |          247 |                     0 |                   0 | Cytoplasm \| Membrane                                                                               |                        53 |                                  7 |                  0 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                         |              14 | GSTZ1 \| CLIC6 \| GSTO2 \| GSTT4 \| HEL-S-21 \| CLIC5 \| CLIC1 \| CLIC4 \| GDAP1L1 \| CLIC3 \| GSTT2 \| GSTT2B \| GDAP1 \| EEF1G                                                                          | 1                     | N/A                     |                    0 |
| [P84157](./P8/P84157/P84157_details.md) | MXRA7       | MXRA7_HUMAN    |                    0.08 |                             1.15 | Downregulated                          |          204 |                     0 |                   1 | Membrane                                                                                            |                        11 |                                 14 |                  0 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                         |               0 | N/A                                                                                                                                                                                                       | N/A                   | N/A                     |                    3 |

